NetworkNewsBreaks – HTC Extraction Systems (TSX.
Post# of 44
(Total Views: 130)
Posted On: 10/02/2019 3:40:37 PM
NetworkNewsBreaks – HTC Extraction Systems (TSX.V: HTC) Achieves Growing Revenues in Q2; Develops CBD FSO Distillate Operation
HTC Extraction Systems (TSX.V: HTC), a gas, liquids and biomass extractor and refiner, recently reported financial results for the second quarter and six-month period ending June 30, 2019 (http://nnw.fm/4XONk). An article discussing the company reads, “HTC Extraction Systems recorded an increase in same-period, year-over-year revenues from operations during the first six months of 2019, rising from $560,260 to $1.85 million, according to unaudited interim condensed consolidated financial results. . . . HTC and its subsidiaries are dedicated to developing their proprietary extraction and purification systems for removing cannabidiol full-spectrum oil (CBD FSO) distillate from acquired hemp biomass and making the remaining hemp byproducts, including other cannabinoids, available for singulation and sale to the cannabinoid pharmaceutical market.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
HTC Extraction Systems (TSX.V: HTC), a gas, liquids and biomass extractor and refiner, recently reported financial results for the second quarter and six-month period ending June 30, 2019 (http://nnw.fm/4XONk). An article discussing the company reads, “HTC Extraction Systems recorded an increase in same-period, year-over-year revenues from operations during the first six months of 2019, rising from $560,260 to $1.85 million, according to unaudited interim condensed consolidated financial results. . . . HTC and its subsidiaries are dedicated to developing their proprietary extraction and purification systems for removing cannabidiol full-spectrum oil (CBD FSO) distillate from acquired hemp biomass and making the remaining hemp byproducts, including other cannabinoids, available for singulation and sale to the cannabinoid pharmaceutical market.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)